Department of Obstetrics and Gynecology, Peking University People' Hospital, Beijing, PR China.
Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, PR China.
PLoS One. 2019 Jul 26;14(7):e0220200. doi: 10.1371/journal.pone.0220200. eCollection 2019.
Correlation with HPV viral load and worsening cervical lesions had been reported, but its potential for triage after primary HPV screening has not been adequately explored, especially when combined with HPV-16/18 genotyping.
To evaluate combinations of human papillomavirus (HPV) viral load and genotyping for HPV-16/18 as secondary screening strategies.
The Shenzhen Cervical Cancer Screening Trial Ⅱ (SHENCCAST Ⅱ) database was re-analyzed to explore new screening algorithms using the results of Hybrid Capture 2 (HC2), Mass Array Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass spectrometry System (MALDI-TOF-MS) and the ThinPrep cytologic test (TCT) obtained by endocervical sampling.
Compared with the recommended screening strategy of genotyping HPV-16/18 plus reflex to cytology, using viral load (10 RLU/CO as threshold) plus reflex to cytology resulted in less cytology but had a significantly higher sensitivity for cervical intraepithelial neoplasia 2+ (CIN2+)/CIN3+ without considerable changes in specificity and referral rates. Both of the strategy of using viral load ≥10 RLU/CO as cut-point for immediate colposcopy followed by triage genotyping HPV-16/18 for the other positive (≥1<10 RLU/CO) and the strategy of referring HPV-16/18 positives for immediate colposcopy followed by triage viral load (10 RLU/CO as threshold) for non-HPV-16/18 positives had comparable screening efficacy with algorithims that contain cytology.
Primary HPV screening with triage of HPV-positive women by a combination of viral load and genotyping for HPV-16/18 provides good balance between sensitivity and specificity, the number of tests required, and referral rates.
已有研究报道 HPV 病毒载量与宫颈病变恶化相关,但 HPV 病毒载量在 HPV 初筛后的分流作用尚未得到充分探讨,特别是与 HPV-16/18 基因分型联合应用时。
评估 HPV 病毒载量和 HPV-16/18 基因分型联合检测作为 HPV 初筛后二级筛查策略的应用价值。
利用杂交捕获 2 代(HC2)、MALDI-TOF-MS 基因芯片技术和液基细胞学检测(TCT)对深圳市宫颈癌筛查研究Ⅱ(SHENCCAST Ⅱ)数据库进行再分析,探索新的筛查方案。
与推荐的 HPV-16/18 基因分型联合细胞学检测的筛查策略相比,HPV 病毒载量(10 RLU/CO 为界值)联合细胞学检测策略可减少细胞学检查数量,但 CIN2+/CIN3+的敏感性显著提高,而特异性和转诊率无明显变化。HPV 病毒载量≥10 RLU/CO 者行阴道镜检查,其余 HPV 阳性(1<HPV 载量<10 RLU/CO)者行 HPV-16/18 基因分型检测,或 HPV 阳性者行阴道镜检查,HPV-16/18 阴性者行 HPV 病毒载量检测(10 RLU/CO 为界值)的筛查效果与包含细胞学检查的策略相当。
HPV 初筛联合 HPV 病毒载量和 HPV-16/18 基因分型检测的分流方法具有较好的敏感性和特异性、检测数量和转诊率之间的平衡。